Michael Alifrangis

Michael Alifrangis

Associate Professor

Member of:

  • DRUGS team

ORCID: 0000-0002-3835-3333

Publication year:
All
11 - 13 out of 13Page size: 10
Sort by: 1st author
  1. Published

    Trends of Plasmodium falciparum prevalence in two communities of Muheza district North-eastern Tanzania: Correlation between parasite prevalence, malaria interventions and rainfall in the context of re-emergence of malaria after two decades of progressively declining transmission

    Ishengoma, D. S., Mmbando, B. P., Mandara, C. I., Chiduo, M. G., Francis, F., Timiza, W., Msemo, H., Kijazi, A., Lemnge, M. M., Malecela, M. N., Snow, R. W., Alifrangis, Michael & Bygbjerg, Ib Christian, 2018, In: Malaria Journal. 17, 1, 10 p., 252.

    Research output: Contribution to journal › Journal article › Research › peer-review

  2. Published

    Impact of treatment and re-treatment with artemether-lumefantrine and artesunate-amodiaquine on selection of Plasmodium falciparum multidrug resistance gene-1 polymorphisms in the Democratic Republic of Congo and Uganda

    Baraka, V., Mavoko, H. M., Nabasumba, C., Francis, F., Lutumba, P., Alifrangis, Michael & Van Geertruyden, J., Feb 2018, In: PLOS ONE. 13, 2, 18 p., e0191922.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Population pharmacokinetics of the antimalarial Amodiaquine. A pooled analysis to optimize dosing

    WWARN Amodiaquine PK Study Group , W. A. P. S. G., 2018, In: Antimicrobial Agents and Chemotherapy. 62, 10, 18 p., e02193-17.

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1 2 Next

ID: 11975